celecoxib has been researched along with Ischemia in 4 studies
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Whether the chronic administration of HMG-CoA reductase inhibitors provides similar protection remains controversial and is unknown in humans." | 2.77 | Loss of the preconditioning effect of rosuvastatin during sustained therapy: a human in vivo study. ( Gori, T; Liuni, A; Luca, MC; Parker, JD, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Margulis, K | 1 |
| Neofytou, EA | 1 |
| Beygui, RE | 1 |
| Zare, RN | 1 |
| Lada-Moldovan, L | 1 |
| Kaloustian, S | 1 |
| Bah, TM | 1 |
| Girard, SA | 1 |
| Déry, MA | 1 |
| Rousseau, G | 1 |
| Dikici, MB | 1 |
| Coskunfirat, OK | 1 |
| Uslu, A | 1 |
| Liuni, A | 1 |
| Luca, MC | 1 |
| Gori, T | 1 |
| Parker, JD | 1 |
1 trial available for celecoxib and Ischemia
| Article | Year |
|---|---|
Loss of the preconditioning effect of rosuvastatin during sustained therapy: a human in vivo study.
Topics: Adolescent; Adult; Analysis of Variance; Blood Flow Velocity; Celecoxib; Cyclooxygenase 2 Inhibitors | 2012 |
3 other studies available for celecoxib and Ischemia
| Article | Year |
|---|---|
Celecoxib Nanoparticles for Therapeutic Angiogenesis.
Topics: Angiogenesis Inducing Agents; Animals; Blood Vessels; Celecoxib; Disease Models, Animal; Humans; Isc | 2015 |
Chronic pretreatment with celecoxib reduces infarct size.
Topics: Animals; Celecoxib; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Infusions, Parenteral; Isch | 2009 |
Effect of cyclooxygenase-2 on ischemic preconditioning of skin flaps.
Topics: Animals; Celecoxib; Cyclooxygenase 2 Inhibitors; Female; Ischemia; Ischemic Preconditioning; Pyrazol | 2009 |